您好, 歡迎來到環(huán)保在線! 登錄| 免費(fèi)注冊| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:上海谷研實(shí)業(yè)有限公司>>生化試劑>>分離材料及耗材類4>> Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0
參 考 價 | 面議 |
產(chǎn)品型號
品 牌
廠商性質(zhì)代理商
所 在 地上海市
更新時間:2024-01-09 16:14:12瀏覽次數(shù):1093次
聯(lián)系我時,請告知來自 環(huán)保在線公司專業(yè)銷售生化試劑,氨基酸類,酶類,蛋白質(zhì)類,植物激素及核酸類,碳水化合物類,色素類,緩沖劑類,培養(yǎng)基類,涉及到分析科學(xué),生命科學(xué),化學(xué),材料科學(xué)。了解更多產(chǎn)品!
Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0Amberlite XAD4離子交換大孔吸附樹脂/Amberlite XAD4 BR,20-60目 00克 ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌, 37380-42-0 RT
500克 ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,
產(chǎn)品名稱 | Amberlite XAD4離子交換大孔吸附樹脂 37380-42-0 |
英文名稱 | 37380-42-0 |
規(guī)格 | 可接受大包訂制 |
中文名稱:
英文名稱: 37380-42-0
產(chǎn)品規(guī)格: BR,20-60目
包裝:500毫升
:37380-42-0
級別:BR
Autoignition temp:800 °F
Matrix:styrene-divinylbenzene
Particle size :20~60 mesh
Pore size:~0.98mL/g pore volume;40 Å mean pore size
Surface area:725 m2/g
Density:.02 g/mL at 25℃(true wet);.08 g/mL at 25℃(skeletal)
性狀:玻璃粉,大孔酚醛系吸附樹脂。易于吸附大分子量的水溶性有機(jī)物
用途:生化研究。吸附樹脂用于去除蛋白、高分子量著色劑、有機(jī)雜質(zhì)。用于純化藥物方面的具體應(yīng)用如下:氨基酸和生物堿類物質(zhì)的脫色、蛋白質(zhì)去苦味、酶載體;提取蛋白質(zhì)、多肽和動植物有效成份;水解:脫色、除去蛋白質(zhì)、雜質(zhì)離子,糠醛等會影響口味的離子;有機(jī)酸:脫色(發(fā)酵法有機(jī)酸,如檸檬酸、乳酸)
保存:RT
是我司的優(yōu)勢產(chǎn)品,在行業(yè)中獲得許多客戶的贊譽(yù)。平易的價格,讓您補(bǔ)足實(shí)驗(yàn)“糧響”。我司專業(yè)供應(yīng)科研實(shí)驗(yàn)試劑,保質(zhì)保量。嚴(yán)格操作,技術(shù)成熟??蒲胁┐缶睿瑢W(xué)科之間相互滲透,我們以滿足客戶需求為己任,力求全面服務(wù)于新老客戶。
aminoethyl]-benzenemethanol
L-Norpseudoephedrine (5 mg) (-)-Norpseudoephedrine; (αR)-α-[(R)--aminoethyl]-benzenemethanol
L-Norpseudoephedrine (50 mg) (-)-Norpseudoephedrine; (αR)-α-[(R)--aminoethyl]-benzenemethanol
Alprenolol (hydrochloride) (00 mg) H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (25 mg) H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (250 mg) H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (50 mg) H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Metolazone (0 mg) SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (00 mg) SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (25 mg) SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (50 mg) SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
7-methyl Guanosine (00 mg) 7-
7-methyl Guanosine (25 mg) 7-
7-methyl Guanosine (250 mg) 7-
7-methyl Guanosine (50 mg) 7-
Lofexidine (hydrochloride) ( g) 2-[-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-H-imidazole, monohydrochlorideSR 555 (hydrochloride) (5 mg) -(4-((4’-(,,,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-[,’-biphenyl]-4-yl)methyl)piperazin--yl)ethanone, monohydrochloride; SR 555 (hydrochloride)
SR 3335 ( mg) N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
SR 3335 (0 mg) N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
SR 3335 (25 mg) N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
SR 3335 (5 mg) N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
Canertinib (hydrochloride) (0 mg) N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (25 mg) N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (5 mg) N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (50 mg) N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
-hydroxy Vitamin D2 ( mg) 4-methylene-5Z-[2E-[(R,3aS)-octahydro-7aR-methyl-R-[R,4,5-trimethyl-2E-hexen--yl]-4H-inden-4-ylidene]ethylidene]-,3S-cyclohexanediol; -Hydroxyergocalciferol|Hectorol|TSA 840|Doxercalciferol; -hydroxy Vitamin D2
請輸入賬號
請輸入密碼
請輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),環(huán)保在線對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。